Today's Date: September 25, 2023
Guidewire Optimistic About New Direction of California Insurance   •   France Announces €40 Million in New Funding to Education Cannot Wait at Global Citizen Festival   •   Shift4 Partners with Give Lively to Offer Powerful Fundraising Solution to Nonprofits   • collaborates with   •   2023 GLOBAL CITIZEN FESTIVAL SEES $240 MILLION COMMITMENT FROM FRANCE AND NORWAY TO COMBAT THE GLOBAL FOOD CRISIS   •   Wondershare FamiSafe 7.0 safeguarding Children with AI   •   Sixth Annual War Heroes on Water Charity Sportfishing Tournament Kicks Off, Bringing Hope and Healing to Combat-Wounded Veterans   •   Live Good Inc. Celebrates Diversity and Unity: A Beacon of Progress in the Spirit of Crissy Field, Angel Island and the Buffalo   •   THE BLACK WOMEN'S AGENDA, INC. HOSTS 46TH ANNUAL SYMPOSIUM TOWN HALL & AWARDS LUNCHEON   •   2023 Gangnam Festival to be Held in Gangnam, the Heart of K-pop   •   Intel Editorial: Intel Addresses Semiconductor Workforce Shortage   •   PRAIRIE VIEW A&M UNIVERSITY ANNOUNCES 2023-2024 WRITER-IN-RESIDENCE ATTICA LOCKE   •   Student Entrepreneurs from Yale University Win Prestigious $1 Million 2023 Hult Prize   •   A Meyers Manx Collaboration with Artist Sage Vaughn Contributes $200,000 to Arts Education Fundraiser   •   65+ Populations in Upstate NY's 4 Largest Regions Surging, Getting Poorer; AARP NY to Meet with Local Leaders   •   Statement by the Prime Minister on Yom Kippur   •   Reactive Technologies’ Grid Inertia Measurement Tech to Enable Offshore Wind Rollout in Taiwan   •   No more oil, gas and coal. Two nation-states join growing bloc of countries calling for a Fossil Fuel Non-Proliferation Treaty   •   Statement by Minister Khera on Yom Kippur   •   Joint Statement on the Importance of Comprehensive, Multidisciplinary and Collaborative Care for Patients with Peripheral Artery
Bookmark and Share

Perfuze Announces Appointment of New Chair of the Board

GALWAY, Ireland , June 09 /Businesswire/ - Perfuze, a medical device company developing next-generation "super-bore" catheter technology to treat acute ischemic stroke, is pleased to announce the appointment of Hooman Hakami as the new Chair of the Board. This appointment reflects Perfuze's commitment to bring devices to market that have the potential to transform the treatment of acute ischemic stroke. Hooman brings a wealth of experience and expertise to Perfuze, making him an invaluable addition to the company's leadership team. With an impressive track record in the medical device industry, Hooman has held prominent leadership positions within Medtronic and GE Healthcare, driving innovation, growth, and profitability.

As the new Chair of the Board, Hooman will play a pivotal role in guiding Perfuze's strategic direction and spearheading the company's mission to transform the treatment landscape for acute ischemic stroke. His previous Board experience and strategic insights will be instrumental in supporting the advance of Perfuze's groundbreaking technologies and therapies, ultimately improving patient outcomes. "I am honored to join Perfuze as the Chair of the Board," said Hooman. "Perfuze's commitment to developing innovative solutions for stroke aligns perfectly with my enthusiasm for advancing medical technologies that have the potential to significantly impact patients' lives. I am joining at an exciting time in the company’s development, as we move towards enrolling our first patient in our upcoming pivotal US IDE clinical study. I look forward to collaborating closely with the talented team at Perfuze to achieve our shared vision."

Perfuze's CEO, Wayne Allen, expressed his enthusiasm about the appointment, stating, "We are delighted to welcome Hooman to Perfuze. His exceptional leadership qualities and extensive industry experience will undoubtedly strengthen our board and accelerate our journey towards redefining stroke treatment. We believe that Hooman's guidance will be invaluable as we continue to push the boundaries of medical innovation."

About Perfuze

Based in Galway, Ireland, Perfuze is a dynamic medical device company that has developed super-bore diameter aspiration technology that is designed to navigate complex neurovascular anatomy. The company’s pipeline of products is designed to facilitate fast, complete clot removal following acute ischemic stroke. Perfuze is committed to continuing its research and development efforts to advance the field of neurovascular care and aims to provide neurointerventional physicians with advanced tools to restore blood flow, minimize brain damage, and improve patient outcomes.

For more information, please visit

STORY TAGS: Personnel, Medical Devices, Health, Ireland, Europe,


White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News